scispace - formally typeset
E

Eleni Maria Varypataki

Researcher at University of Zurich

Publications -  15
Citations -  629

Eleni Maria Varypataki is an academic researcher from University of Zurich. The author has contributed to research in topics: CD8 & Cytotoxic T cell. The author has an hindex of 9, co-authored 12 publications receiving 470 citations. Previous affiliations of Eleni Maria Varypataki include Leiden University.

Papers
More filters
Journal ArticleDOI

Poly-(lactic-co-glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation

TL;DR: It is postulate that particle internalization is of crucial importance and therefore particulate vaccines should be formulated in the nano- but not micro-size range to achieve efficient uptake, significant MHC class I cross-presentation and effective T and B cell responses.
Journal ArticleDOI

Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles

TL;DR: Findings make these two particulate, biodegradable delivery systems promising candidates as delivery platforms for SLP-based immunotherapy of cancer.
Journal ArticleDOI

Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity

TL;DR: Cationic liposomes loaded with SLP and poly(I:C) have potential as a powerful therapeutic cancer vaccine formulation and showed an at least 25 fold increase over the T cell frequency induced by the poly( I:C)-adjuvanted soluble SLP.
Journal ArticleDOI

Novel Hollow Microneedle Technology for Depth-Controlled Microinjection-Mediated Dermal Vaccination: A Study with Polio Vaccine in Rats

TL;DR: A hollow microneedle technology for dermal vaccination that enables fundamental research on factors, such as insertion depth and volume, and insertion angle, on the immune response is successfully developed.